Cargando…
Erratum: PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors
Autores principales: | Smith, Amanda M., Zhang, Christine R.C., Cristino, Alexandre S., Grady, John P., Fink, J. Lynn, Moore, Andrew S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6980628/ https://www.ncbi.nlm.nih.gov/pubmed/32076493 http://dx.doi.org/10.18632/oncotarget.27402 |
Ejemplares similares
-
PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors
por: Smith, Amanda M., et al.
Publicado: (2019) -
Erratum to “A Case of Abdominal Sarcoidosis in a Patient with Acute Myeloid Leukemia”
por: Baskaran, Vadsala, et al.
Publicado: (2013) -
Erratum to “DNMT3A Mutations in Patients with Acute Myeloid Leukemia in South Brazil”
por: Pezzi, Annelise, et al.
Publicado: (2014) -
Erratum: Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia
por: Lee-Sherick, A B, et al.
Publicado: (2016) -
Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum]
Publicado: (2018)